業務
貨幣單位:EUR
2025/FY
名稱營收比例
Research and development of PRAME-directed immunotherapies that harness the power of T cells for4,826.6萬100.00%
地區
貨幣單位:EUR
2025/FY
名稱營收比例
Moderna, United States3,724.7萬77.17%
Bristol-Myers-Squibb (BMS) United States1,101.9萬22.83%